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Abstract
A novel parvovirus, human bocavirus (HBoV), was first discov-
ered in children with respiratory tract infections in Sweden.
A retrospective study of HBoV in faecal samples from children
suffering from diarrhea, covering a 3-year period (November
2000 to October 2003) in Wuhan, China, was undertaken. PCR
assays were used to evaluate 214 faecal samples and to deter-
mine the role of HBoV in diarrhoea. Among 196 virus-infected
children with diarrhoea, 2.55% were HBoV-positive; however, all
HBoV-positive patients were co-infected with common enteric
viruses. This result does not support the notion that HBoV is a
viral agent causing acute diarrhoea.
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In 2005, Allander et al.[1]described a previously uncharacter-
ized virus in nasopharyngeal aspirates from children suffering
from respiratory tract diseases, and provisionally named it
human bocavirus (HBoV). Its global prevalence in respiratory
samples from children, infants and rarely, adults with various
respiratory diseases has been reported to be 3–19% [1–10].
Several studies have reported detection of HBoV in 0.8–9.1%
of faecal samples from children with diarrhoea [8,11–13].
This newly identified virus has therefore been described as
an enteric pathogen, and also a respiratory pathogen
[3,4,10,14–16]. To elucidate the possible clinical role of
HBoV infection, we retrospectively investigated faecal sam-
ples from children with diarrhoea in Wuhan, China, for the
presence of the virus using PCR techniques. In this pilot
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study, other common enteric viral aetiologic agents were
also examined.
During a 3-year study period (between November 2000
and October 2003), 214 faecal samples from children aged
<5 years with acute diarrhoea were selected from 1928
stool samples and subjected to PCR and RT-PCR for the
detection of HBoV and other common enteric viruses. HBoV
PCR was carried out using primers from the conserved
region, NP-1, as previously described [1]. At least one viral
agent was detected in 196 faecal samples, with rotavirus
being the most frequently detected. Specimens from 2.55%
(n = 5) of all infected patients were positive for HBoV. The
PCR products were sequenced and the BLAST results showed
99–100% identity with the previously published HBoV
sequence. Rotavirus, astrovirus, human enteric adenovirus,
norovirus and enterovirus-71 were detected in 95%
(n = 186), 43% (n = 84), 10.2% (n = 20), 7.1% (n = 14) and
1% (n = 2) of infected children, respectively. No sapovirus
was detected. A single viral agent was found in 91 out of the
196 virus-positive faecal samples (46.4% of the study popula-
tion), but no patients were infected with HBoV alone.
Co-infection was found in 105 patients (53.6% of the study
population), 48.5% (n = 95) were infected with two viruses
and 5.1% (n = 10) with three viruses. In particular, all five
human bocavirus-positive patients were co-infected with
rotavirus, and/or astrovirus. The detection rates of the dif-
ferent viruses are summarized in Table 1 and Fig. 1.
In this retrospective study, the detection rate of HBoV
(2.55%) was comparable to previously reported rates
[10,14,15], and simultaneous detection of HBoV and other
agents was frequent for enteric specimens. In our study, the
lower prevalence of HBoV may be the result of study design,
techniques used, or differences in patient groups. Most
clinically well-characterized patients with acute gastroenteri-
tis, which may be the major manifestation of rotavirus and
other common enteric virus infections, were included.
Therefore the variations in viral prevalence may be explained
by differences in the study populations and patient character-
istics, as the majority of currently published studies have
been performed retrospectively. A striking finding was the
high number of co-infections. The proportion of multiple
viral infections in HBoV-infected patients has been reported
to be between 35% and 91% [2,3,6,7,9]. In this report, con-
current detection of HBoV and other enteric pathogens in
children with gastroenteritis was 100% in HBoV positive chil-
dren, this is the highest co-detection rate reported to date.
It implicated one possible association of HBoV with other
co-infected viruses, for example, the ‘innocent bystander’ in
gastroenteritis, or may be re-infection, viral persistence or
reactivation [17], as HBoV is rarely detected in immuno-
competent adults [5] yet frequently detected in immuno-
suppressed adults [17,18, 38]. The most frequent co-
detection of HBoV and rotavirus supported the notion that
HBoV is not a viral agent causing severe diarrhoea in chil-
dren from Wuhan, China, despite its frequent detection in
faecal samples worldwide.
All HBoV DNA-positive children had diarrhoea. Other
symptoms included fever, cough and vomiting, but nasopha-
ryngeal specimens were not collected because of the original
study design. As HBoV commonly co-infected with rotavirus,
the clinical symptoms were compared with those infected
with rotavirus alone. Co-infection with HBoV did not
increase the clinical symptoms of rotavirus gastroenteritis
and symptoms were clinically similar to single infections.
TABLE 1. HBoV and enteric virus detection in 214 children







as sole agent (%)
Rotavirus 186 (95) 82 (41.8)
Astrovirus 84 (43) 8 (4.1)
Human enteric adenovirus 20 (10.2) 0 (0)
Norovirus 14 (7.1) 1 (0.5)
Human bocavirus 5 (2.55) 0 (0)
Enterovirus-71(EV-71) 2 (1) 0 (0)
Sapovirus 0 (0) 0 (0)
Total 196# 91 (46.4*)
*The numbers in bracket present the percentage of the number of children
infected with virus or with the sole virus in 196 viral infections positive chil-
dren.
#Among 214 faecal samples from children presenting with acute diarrhea, 196
were virally infected patients and another 18 patients scored negative for viral
infection.
FIG. 1. HBoV positive distribution in children infected with common
enteric virus during our study period. The numbers in the grey bars
indicate the frequency of patients co-infected with one, two or three
viruses (expressed as the percentage of total infected patients with
acute diarrhoea). The white portion indicates the frequency of
HBoV-positive samples in the three infected groups.
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Therefore, no HBoV-specific clinical symptoms in children
with diarrhoea can be defined here.
A segment of the HBoV genome from one of the five posi-
tive faecal samples was amplified and sequenced (GenBank
accession number FJ496754). Comparison of the complete
genome from our isolate and 55 published genome sequences
obtained from different countries showed only minor varia-
tions (97.3–100% nucleotide sequence identity). This suggests
that the HBoV found in both respiratory and enteric tracts
probably belong to a single genetic lineage and that the evolu-
tionary relatedness of HBoV strains circulating from 2000 to
2008 does not show specific geographical or temporal varia-
tion. The data available so far indicate that HBoV may be a
highly conserved virus. An interesting phenomenon is the varia-
tion of synonymous codon usage among HBoV genes examined
in our isolate, in which only one out of eight nucleotide sub-
stitutions at amino acid position 474 of VP1 (corresponding to
amino acid position 345 of VP2) changed from Asn (N) to Ser
(S). Thus, although there are a few variations in codon usage
bias among different HBoV isolates, codon usage bias in HBoV
is very low. This agrees with a recent study which showed that
genome-wide mutational pressure, rather than natural selec-
tion for specific-coding triplets, is the main determinant of
codon usage in vertebrate-infecting DNA viruses [19].
In conclusion, our retrospective study identified a 2.55%
HBoV DNA detection rate in children with acute diarrhoea
in Wuhan, China, between November 2000 and October
2003. Although HBoV was not the causative agent for gas-
troenteritis outbreaks in our study period, the question of
whether or not HBoV might require the presence of helper
viruses to establish human illness or may even act as co-fac-
tor for other viral agents, or for viral persistence with low
load after the first infection, remains unknown [3]. As infec-
tions with the related parvovirus B19 often result in a
prolonged virus replication in infected individuals [20], mech-
anisms of persistence may also apply for HBoV.
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